Aduro BioTech

About:

Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.

Website: https://adurolife.com/

Top Investors: Fidelity, OrbiMed, Novartis, Foresite Capital, Jennison Associates

Description:

Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases.It was founded in 2000 and headquartered in Berkeley, California.

Total Funding Amount:

$360M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2000-01-01

Contact Email:

bd(AT)adurobiotech.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2019-02-27

IPO Status:

Delisted

© 2025 bioDAO.ai